INTEST director Karl Johnsen files initial Form 3

INTEST CORP director Karl E. Johnsen has filed a Form 3, which is an initial statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

INTEST CORP director Karl E. Johnsen has filed a Form 3, which is an initial statement of beneficial ownership for insiders. This filing lists him as a director but does not report any share purchases, sales, or other transactions at this time.

Key Terms

Form 3, initial statement of beneficial ownership, reporting insider

3 terms

Form 3 regulatory

"has filed a Form 3, which is an initial statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

initial statement of beneficial ownership regulatory

"Form 3, which is an initial statement of beneficial ownership for insiders"

An initial statement of beneficial ownership is the first regulatory filing an insider or large investor submits to disclose the amount of a company's stock they control or benefit from. It matters to investors because it reveals who has significant influence over a company—like showing who’s holding the cards—and helps track potential conflicts of interest, insider motives, and future buying or selling that can move the stock price.

reporting insider regulatory

"indicates Karl E. Johnsen has become a reporting insider at INTEST CORP"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Karl E. Johnsen's Form 3 mean for INTT investors?

The Form 3 shows Karl E. Johnsen is a director and now formally reports as an insider. It is an initial ownership statement and, in this case, does not disclose any stock purchases, sales, or derivative positions for INTEST CORP.

Does Karl E. Johnsen buy or sell INTEST CORP (INTT) shares in this Form 3?

No, this Form 3 does not show any share purchases or sales. It only establishes Karl E. Johnsen as a reporting director at INTEST CORP, with all transaction-related counts reported as zero in the summary data.

What insider activity is summarized in Karl E. Johnsen's INTT Form 3?

The summary shows zero buys, zero sells, and no derivative exercises or gifts. It indicates Karl E. Johnsen has become a reporting insider at INTEST CORP without any concurrent trading or derivative transactions disclosed in this filing.

Are there any derivative positions reported for Karl E. Johnsen in INTT stock?

No derivative positions are listed for Karl E. Johnsen in this Form 3. The derivative summary is empty and the transaction summary reports zero derivative transactions, meaning no options, warrants, or similar instruments are disclosed here.

How many INTEST CORP (INTT) transactions are shown in this Form 3?

The Form 3 shows no transactions at all for INTEST CORP. Buy, sell, gift, tax withholding, and restructuring transaction counts are all reported as zero, reflecting only an initial insider ownership registration for Karl E. Johnsen.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:32 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Johnsen Karl E

(Last) (First) (Middle)

C/O INTEST CORPORATION

804 EAST GATE DR, SUITE 200

(Street)

MT. LAUREL NEW JERSEY 08054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/17/2026

3. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Duncan Gilmour, Attorney-in-Fact for Karl E. Johnsen	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)